Exploring the underlying mechanisms of Ashitaba in the management of non-alcoholic fatty liver disease by integrating the analysis of transcriptomics and metabolomics

Ashitaba seems to improve glucose intolerance and decrease triglyceride (TG) and total cholesterol (TC), which contribute to the development of non-alcoholic fatty liver disease (NAFLD). However, it remains to be explored the mechanism of Ashitaba in managing NAFLD. We determined the impact of Ashit...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Huan, Li, Yunshan, Xu, Weihong, Liu, Wenjuan, Xie, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618682/
https://www.ncbi.nlm.nih.gov/pubmed/37920601
http://dx.doi.org/10.3389/fmed.2023.1247851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618682/
https://www.ncbi.nlm.nih.gov/pubmed/37920601
http://dx.doi.org/10.3389/fmed.2023.1247851

Ejemplares similares